Events after the Reporting Date "On April 4, 2016, the Company closed a nonbrokered private placement of 1,887,625 shares at a price of $0.20 per share for gross proceeds of $377,525. There were no warrants attached to the financing. "
This above is additional info in the May 31st financials to help support there ability to finance themselves. This is listed under number 13 as Events after the Reporting Date. That date of course would be March 31st 2016.
I think it would be easiest to simply go to the May 31st SEDAR financials and read them yourselves to do your proper dd. On top of this go check out the financials of Replicels competitioin as well as a bunch of other research and development companies to get a general idea of what's up. Check out the financial history of current successful research and development biotech companies who actually have products out there. Do not only dd on this company but general dd on all biotech companies to get a better grasp.
